<DOC>
	<DOCNO>NCT01225354</DOCNO>
	<brief_summary>The purpose study determine Radiesse injection cheek result alter improve first impression self esteem .</brief_summary>
	<brief_title>Injectable Filler Cheek Flattening</brief_title>
	<detailed_description />
	<criteria>Females 30 65 year age Fitzpatrick Skin Color Types ( IVI ) . Have bilateral , fully visible age defect malar area , correspond rating moderate severe SOBER scale . Willingness ability comply protocol requirement , include return followup visit abstain exclusionary procedure duration study . Subjects childbearing potential must negative urine pregnancy test result Visit 1 willing able use acceptable method birth control ( e.g. , barrier method use spermicidal agent , hormonal method , IUD , surgical sterilization , abstinence ) study . Women consider childbearing potential one follow document medical history : postmenopausal least 12 month prior study drug administration without uterus and/or ovary bilateral tubal ligation least 6 month prior study drug administration . absence physical condition accord PI 's discretion Willingness ability provide write photo consent adherence photography procedure ( i.e. , removal jewelry makeup ) . Willingness ability provide write informed consent prior performance study related procedure . Subjects pregnant , nursing , plan become pregnant , and/or use reliable form birth control . Subjects know allergy sensitivity component study medication anesthesia . Subjects prior exposure calcium hydroxylapatite , filler , injection purpose 12 month precede study enrollment duration study ( exclude study drug ) . Subjects prior cosmetic procedure improve malar eminence deficiency ( i.e. , rhytidectomy , low eyelid surgery , cheek implant , CO2/erbium laser resurfacing , Thermage/Thermacool radiofrequency treatment ) visible scar may affect evaluation response and/or quality photography . Subjects soft tissue augmentation malar area previous 6 month . Permanent semipermanent dermal filler malar area . Ablative skin resurface malar area within previous 6 month study . Retinoid , microdermabrasion , prescription level glycolic acid treatment malar area within 2 week prior study participation study . Active infection malar area ( e.g. , acute acne lesion ulcer ) . Marked facial asymmetry , ptosis , excessive dermatochalasis , deep dermal scarring , thick sebaceous skin . Current history chronic drug alcohol abuse . History autoimmune disease . Concurrent therapy , investigator 's opinion , would interfere evaluation safety efficacy study medication . Subjects anticipate need surgery overnight hospitalization study . Subjects , Investigator 's opinion , history poor cooperation , nonÂ¬compliance medical treatment unreliability . Enrollment active study involve use investigational device drug .</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Cheek</keyword>
	<keyword>Cheek flattening</keyword>
	<keyword>Malar deficiency</keyword>
	<keyword>Filler</keyword>
</DOC>